Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Privia Health (PRVA) Cash from Financing Activities (2020 - 2026)

Privia Health has reported Cash from Financing Activities over the past 6 years, most recently at $2.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 246.53% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $6.7 million, up 54.64%, while the annual FY2025 figure was $6.7 million, 54.64% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $2.1 million at Privia Health, up from $431000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $210.8 million in Q2 2021 and troughed at -$30.9 million in Q2 2022.
  • A 5-year average of $10.4 million and a median of $1.5 million in 2023 define the central range for Cash from Financing Activities.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 48229.91% in 2021 and later crashed 114.66% in 2022.
  • Year by year, Cash from Financing Activities stood at $3.2 million in 2021, then tumbled by 38.15% to $2.0 million in 2022, then plummeted by 97.85% to $42000.0 in 2023, then soared by 1373.81% to $619000.0 in 2024, then soared by 246.53% to $2.1 million in 2025.
  • Business Quant data shows Cash from Financing Activities for PRVA at $2.1 million in Q4 2025, $431000.0 in Q3 2025, and $1.9 million in Q2 2025.